0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Gene Transplant Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-12P6034
Home | Market Reports | Health| Health Conditions
Global Gene Transplant Market Insights and Forecast to 2028
BUY CHAPTERS

Global Gene Transplant Market Research Report 2025

Code: QYRE-Auto-12P6034
Report
September 2025
Pages:68
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Gene Transplant Market

The global market for Gene Transplant was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Gene Transplant is an experimental treatment that involves introducing genetic material into a person’s cells to fight or prevent disease. Researchers are studying gene therapy for a number of diseases, such as severe combined immuno-deficiencies, hemophilia, Parkinson"s disease, cancer and even HIV, through a number of different approaches. A gene can be delivered to a cell using a carrier known as a “vector.” The most common types of vectors used in gene therapy are viruses. The viruses used in gene therapy are altered to make them safe, although some risks still exist with gene therapy. The technology is still in its infancy.
In terms of regions, North America is expected to remain the largest market during the forecast period.
This report aims to provide a comprehensive presentation of the global market for Gene Transplant, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gene Transplant.
The Gene Transplant market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Gene Transplant market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gene Transplant companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Gene Transplant Market Report

Report Metric Details
Report Name Gene Transplant Market
Segment by Type
  • Ex Vivo
  • In Vivo
Segment by Application
  • Cancer Diseases
  • Hematological Disease
  • Hereditary Disease
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Gilead (Kite Pharma), Amgen (BioVex), Novartis, Roche (Spark Therapeutics)
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Gene Transplant company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Gene Transplant Market report?

Ans: The main players in the Gene Transplant Market are Gilead (Kite Pharma), Amgen (BioVex), Novartis, Roche (Spark Therapeutics)

What are the Application segmentation covered in the Gene Transplant Market report?

Ans: The Applications covered in the Gene Transplant Market report are Cancer Diseases, Hematological Disease, Hereditary Disease, Others

What are the Type segmentation covered in the Gene Transplant Market report?

Ans: The Types covered in the Gene Transplant Market report are Ex Vivo, In Vivo

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gene Transplant Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Ex Vivo
1.2.3 In Vivo
1.3 Market by Application
1.3.1 Global Gene Transplant Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Cancer Diseases
1.3.3 Hematological Disease
1.3.4 Hereditary Disease
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Gene Transplant Market Perspective (2020-2031)
2.2 Global Gene Transplant Growth Trends by Region
2.2.1 Global Gene Transplant Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Gene Transplant Historic Market Size by Region (2020-2025)
2.2.3 Gene Transplant Forecasted Market Size by Region (2026-2031)
2.3 Gene Transplant Market Dynamics
2.3.1 Gene Transplant Industry Trends
2.3.2 Gene Transplant Market Drivers
2.3.3 Gene Transplant Market Challenges
2.3.4 Gene Transplant Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Gene Transplant Players by Revenue
3.1.1 Global Top Gene Transplant Players by Revenue (2020-2025)
3.1.2 Global Gene Transplant Revenue Market Share by Players (2020-2025)
3.2 Global Gene Transplant Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Gene Transplant Revenue
3.4 Global Gene Transplant Market Concentration Ratio
3.4.1 Global Gene Transplant Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gene Transplant Revenue in 2024
3.5 Global Key Players of Gene Transplant Head office and Area Served
3.6 Global Key Players of Gene Transplant, Product and Application
3.7 Global Key Players of Gene Transplant, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Gene Transplant Breakdown Data by Type
4.1 Global Gene Transplant Historic Market Size by Type (2020-2025)
4.2 Global Gene Transplant Forecasted Market Size by Type (2026-2031)
5 Gene Transplant Breakdown Data by Application
5.1 Global Gene Transplant Historic Market Size by Application (2020-2025)
5.2 Global Gene Transplant Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Gene Transplant Market Size (2020-2031)
6.2 North America Gene Transplant Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Gene Transplant Market Size by Country (2020-2025)
6.4 North America Gene Transplant Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Gene Transplant Market Size (2020-2031)
7.2 Europe Gene Transplant Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Gene Transplant Market Size by Country (2020-2025)
7.4 Europe Gene Transplant Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Gene Transplant Market Size (2020-2031)
8.2 Asia-Pacific Gene Transplant Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Gene Transplant Market Size by Region (2020-2025)
8.4 Asia-Pacific Gene Transplant Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Gene Transplant Market Size (2020-2031)
9.2 Latin America Gene Transplant Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Gene Transplant Market Size by Country (2020-2025)
9.4 Latin America Gene Transplant Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Gene Transplant Market Size (2020-2031)
10.2 Middle East & Africa Gene Transplant Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Gene Transplant Market Size by Country (2020-2025)
10.4 Middle East & Africa Gene Transplant Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Gilead (Kite Pharma)
11.1.1 Gilead (Kite Pharma) Company Details
11.1.2 Gilead (Kite Pharma) Business Overview
11.1.3 Gilead (Kite Pharma) Gene Transplant Introduction
11.1.4 Gilead (Kite Pharma) Revenue in Gene Transplant Business (2020-2025)
11.1.5 Gilead (Kite Pharma) Recent Development
11.2 Amgen (BioVex)
11.2.1 Amgen (BioVex) Company Details
11.2.2 Amgen (BioVex) Business Overview
11.2.3 Amgen (BioVex) Gene Transplant Introduction
11.2.4 Amgen (BioVex) Revenue in Gene Transplant Business (2020-2025)
11.2.5 Amgen (BioVex) Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Gene Transplant Introduction
11.3.4 Novartis Revenue in Gene Transplant Business (2020-2025)
11.3.5 Novartis Recent Development
11.4 Roche (Spark Therapeutics)
11.4.1 Roche (Spark Therapeutics) Company Details
11.4.2 Roche (Spark Therapeutics) Business Overview
11.4.3 Roche (Spark Therapeutics) Gene Transplant Introduction
11.4.4 Roche (Spark Therapeutics) Revenue in Gene Transplant Business (2020-2025)
11.4.5 Roche (Spark Therapeutics) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Gene Transplant Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Ex Vivo
 Table 3. Key Players of In Vivo
 Table 4. Global Gene Transplant Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Gene Transplant Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Gene Transplant Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Gene Transplant Market Share by Region (2020-2025)
 Table 8. Global Gene Transplant Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Gene Transplant Market Share by Region (2026-2031)
 Table 10. Gene Transplant Market Trends
 Table 11. Gene Transplant Market Drivers
 Table 12. Gene Transplant Market Challenges
 Table 13. Gene Transplant Market Restraints
 Table 14. Global Gene Transplant Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Gene Transplant Market Share by Players (2020-2025)
 Table 16. Global Top Gene Transplant Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Transplant as of 2024)
 Table 17. Ranking of Global Top Gene Transplant Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Gene Transplant Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Gene Transplant, Headquarters and Area Served
 Table 20. Global Key Players of Gene Transplant, Product and Application
 Table 21. Global Key Players of Gene Transplant, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Gene Transplant Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Gene Transplant Revenue Market Share by Type (2020-2025)
 Table 25. Global Gene Transplant Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Gene Transplant Revenue Market Share by Type (2026-2031)
 Table 27. Global Gene Transplant Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Gene Transplant Revenue Market Share by Application (2020-2025)
 Table 29. Global Gene Transplant Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Gene Transplant Revenue Market Share by Application (2026-2031)
 Table 31. North America Gene Transplant Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Gene Transplant Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Gene Transplant Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Gene Transplant Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Gene Transplant Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Gene Transplant Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Gene Transplant Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Gene Transplant Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Gene Transplant Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Gene Transplant Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Gene Transplant Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Gene Transplant Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Gene Transplant Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Gene Transplant Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Gene Transplant Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Gilead (Kite Pharma) Company Details
 Table 47. Gilead (Kite Pharma) Business Overview
 Table 48. Gilead (Kite Pharma) Gene Transplant Product
 Table 49. Gilead (Kite Pharma) Revenue in Gene Transplant Business (2020-2025) & (US$ Million)
 Table 50. Gilead (Kite Pharma) Recent Development
 Table 51. Amgen (BioVex) Company Details
 Table 52. Amgen (BioVex) Business Overview
 Table 53. Amgen (BioVex) Gene Transplant Product
 Table 54. Amgen (BioVex) Revenue in Gene Transplant Business (2020-2025) & (US$ Million)
 Table 55. Amgen (BioVex) Recent Development
 Table 56. Novartis Company Details
 Table 57. Novartis Business Overview
 Table 58. Novartis Gene Transplant Product
 Table 59. Novartis Revenue in Gene Transplant Business (2020-2025) & (US$ Million)
 Table 60. Novartis Recent Development
 Table 61. Roche (Spark Therapeutics) Company Details
 Table 62. Roche (Spark Therapeutics) Business Overview
 Table 63. Roche (Spark Therapeutics) Gene Transplant Product
 Table 64. Roche (Spark Therapeutics) Revenue in Gene Transplant Business (2020-2025) & (US$ Million)
 Table 65. Roche (Spark Therapeutics) Recent Development
 Table 66. Research Programs/Design for This Report
 Table 67. Key Data Information from Secondary Sources
 Table 68. Key Data Information from Primary Sources
 Table 69. Authors List of This Report


List of Figures
 Figure 1. Gene Transplant Picture
 Figure 2. Global Gene Transplant Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Gene Transplant Market Share by Type: 2024 VS 2031
 Figure 4. Ex Vivo Features
 Figure 5. In Vivo Features
 Figure 6. Global Gene Transplant Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Gene Transplant Market Share by Application: 2024 VS 2031
 Figure 8. Cancer Diseases Case Studies
 Figure 9. Hematological Disease Case Studies
 Figure 10. Hereditary Disease Case Studies
 Figure 11. Others Case Studies
 Figure 12. Gene Transplant Report Years Considered
 Figure 13. Global Gene Transplant Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 14. Global Gene Transplant Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Gene Transplant Market Share by Region: 2024 VS 2031
 Figure 16. Global Gene Transplant Market Share by Players in 2024
 Figure 17. Global Top Gene Transplant Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Transplant as of 2024)
 Figure 18. The Top 10 and 5 Players Market Share by Gene Transplant Revenue in 2024
 Figure 19. North America Gene Transplant Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. North America Gene Transplant Market Share by Country (2020-2031)
 Figure 21. United States Gene Transplant Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Canada Gene Transplant Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Gene Transplant Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Gene Transplant Market Share by Country (2020-2031)
 Figure 25. Germany Gene Transplant Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. France Gene Transplant Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. U.K. Gene Transplant Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Italy Gene Transplant Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Russia Gene Transplant Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Nordic Countries Gene Transplant Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Gene Transplant Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Gene Transplant Market Share by Region (2020-2031)
 Figure 33. China Gene Transplant Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Japan Gene Transplant Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. South Korea Gene Transplant Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Southeast Asia Gene Transplant Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. India Gene Transplant Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Australia Gene Transplant Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Gene Transplant Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Gene Transplant Market Share by Country (2020-2031)
 Figure 41. Mexico Gene Transplant Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Brazil Gene Transplant Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Gene Transplant Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Gene Transplant Market Share by Country (2020-2031)
 Figure 45. Turkey Gene Transplant Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Saudi Arabia Gene Transplant Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. UAE Gene Transplant Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Gilead (Kite Pharma) Revenue Growth Rate in Gene Transplant Business (2020-2025)
 Figure 49. Amgen (BioVex) Revenue Growth Rate in Gene Transplant Business (2020-2025)
 Figure 50. Novartis Revenue Growth Rate in Gene Transplant Business (2020-2025)
 Figure 51. Roche (Spark Therapeutics) Revenue Growth Rate in Gene Transplant Business (2020-2025)
 Figure 52. Bottom-up and Top-down Approaches for This Report
 Figure 53. Data Triangulation
 Figure 54. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS